| Simultaneous Venoarterial Extracorporeal Membrane Oxygenation and Percutaneous Left Ventricular Decompression Therapy with Impella Is Associated with Improved Outcomes in Refractory Cardiogenic Shock |
34 |
| Left Ventricular Unloading During Veno-Arterial ECMO: A Simulation Study |
18 |
| Left Ventricular Assist Device Infections: A Systematic Review |
18 |
| Outcomes with the Tandem Protek Duo Dual-Lumen Percutaneous Right Ventricular Assist Device |
14 |
| Del Nido Cardioplegia for Myocardial Protection in Adult Cardiac Surgery: A Systematic Review and Meta-Analysis |
13 |
| Circulatory Support with Extracorporeal Membrane Oxygenation and/or Impella for Cardiogenic Shock During Myocardial Infarction |
13 |
| Large Dual-Lumen Extracorporeal Membrane Oxygenation Cannulas Are Associated with More Intracranial Hemorrhage |
12 |
| EC-VAD: Combined Use of Extracorporeal Membrane Oxygenation and Percutaneous Microaxial Pump Left Ventricular Assist Device |
12 |
| HVAD Waveform Analysis as a Noninvasive Marker of Pulmonary Capillary Wedge Pressure: A First Step Toward the Development of a Smart Left Ventricular Assist Device Pump |
10 |
| Evaluation of Systemic Heparin Versus Bivalirudin in Adult Patients Supported by Extracorporeal Membrane Oxygenation |
10 |
| Durable Biventricular Support Using Right Atrial Placement of the HeartWare HVAD |
9 |
| Medical Therapy As Compared To Surgical Device Exchange for Left Ventricular Assist Device Thrombosis: A Systematic Review and Meta-Analysis |
9 |
| Left Lateral Thoracotomy for Centrifugal Continuous-Flow Left Ventricular Assist Device Placement: An Analysis from the Mechanical Circulatory Support Research Network |
9 |
| What Causes LVAD-Associated Ischemic Stroke? Surgery, Pump Thrombosis, Antithrombotics, and Infection |
9 |
| Clinical Outcomes of Impella Microaxial Devices Used to Salvage Cardiogenic Shock as a Bridge to Durable Circulatory Support or Cardiac Transplantation |
8 |
| Left Ventricular Assist Device Outflow Graft Obstruction: A Complication Specific to Polytetrafluoroethylene Covering. A Word of Caution! |
8 |
| Effect of Impella During Veno-Arterial Extracorporeal Membrane Oxygenation on Pulmonary Artery Flow as Assessed by End-Tidal Carbon Dioxide |
8 |
| Assessing Computational Model Credibility Using a Risk-Based Framework: Application to Hemolysis in Centrifugal Blood Pumps |
7 |
| New Approach for Differentiation of Bone Marrow Mesenchymal Stem Cells Toward Chondrocyte Cells With Overexpression of MicroRNA-140 |
7 |
| Incidence and Impact of On-Cardiopulmonary Bypass Vasoplegia During Heart Transplantation |
7 |
| Impact of Anticoagulation and Circuit Technology on Complications During Extracorporeal Membrane Oxygenation |
7 |
| F-18-FDG PET/CT in the Diagnosis and Management of Continuous Flow Left Ventricular Assist Device Infections: A Case Series and Review of the Literature |
7 |
| Retrospective Analysis of Transcranial Doppler Patterns in Veno-Arterial Extracorporeal Membrane Oxygenation Patients: Feasibility of Cerebral Circulatory Arrest Diagnosis |
6 |
| Left Ventricular Distension in Veno-arterial Extracorporeal Membrane Oxygenation: From Mechanics to Therapies |
6 |
| Determination of Optimal Coronary Flow for the Preservation of Donation after Circulatory Death in Murine Heart Model |
6 |
| Predictors of Survival for Nonhighly Selected Patients Undergoing Resuscitation With Extracorporeal Membrane Oxygenation After Cardiac Arrest |
6 |
| Preoperative Nutritional Assessment with the Prognostic Nutrition Index in Patients Undergoing Left Ventricular Assist Device Implantation |
6 |
| Highlights from the Extracorporeal Life Support Organization Registry: 2006-2017 |
6 |
| Quantitative Characterization of Shear-Induced Platelet Receptor Shedding: Glycoprotein Ib, Glycoprotein VI, and Glycoprotein IIb/IIIa |
6 |
| The Starling Relationship and Veno-Arterial ECMO: Ventricular Distension Explained |
6 |
| A Proof of Concept Study, Demonstrating Extracorporeal Carbon Dioxide Removal Using Hemodialysis with a Low Bicarbonate Dialysate |
6 |
| Sedation Practice in Extracorporeal Membrane Oxygenation-Treated Patients with Acute Respiratory Distress Syndrome: A Retrospective Study |
6 |
| Antithrombin During Extracorporeal Membrane Oxygenation in Adults: National Survey and Retrospective Analysis |
6 |
| Association of Inflow Cannula Position with Left Ventricular Unloading and Clinical Outcomes in Patients with HeartMate II Left Ventricular Assist Device |
6 |
| Bivalirudin Dosing Requirements in Adult Patients on Extracorporeal Life Support With or Without Continuous Renal Replacement Therapy |
5 |
| Human Umbilical Vessels: Choosing the Optimal Decellularization Method |
5 |
| Determinants of Improvement in Cardiopulmonary Exercise Testing After Left Ventricular Assist Device Implantation |
5 |
| Veno-Venous Extracorporeal Membrane Oxygenation for Respiratory Failure: How Long Is Too Long? |
5 |
| In Vivo 5 Day Animal Studies of a Compact, Wearable Pumping Artificial Lung |
5 |
| Survival and Functional Status After Bridge-to-Transplant with a Left Ventricular Assist Device |
5 |
| Gastrointestinal Bleeding in Left Ventricular Assist Device: Octreotide and Other Treatment Modalities |
5 |
| Sex-Specific Outcome Disparities in Patients Receiving Continuous-Flow Left Ventricular Assist Devices: A Systematic Review and Meta-analysis |
5 |
| The Impact of Infection and Elevated INR in LVAD-Associated Intracranial Hemorrhage: A Case-Crossover Study |
5 |
| The Relationship of Anxiety, Depression, and Quality of Life in Adults With Left Ventricular Assist Devices |
5 |
| Impact of 30 Day Readmission After Left Ventricular Assist Device Implantation |
5 |
| Evaluating Mortality Risk Adjustment Among Children Receiving Extracorporeal Support for Respiratory Failure |
4 |
| Increased Risk of Bleeding in Left Ventricular Assist Device Patients Treated with Enoxaparin as Bridge to Therapeutic International Normalized Ratio |
4 |
| Preclinical Evaluation of the EVAHEART 2 Centrifugal Left Ventricular Assist Device in Bovines |
4 |
| Suitability of 3D-Printed Root Models for the Development of Transcatheter Aortic Root Repair Technologies |
4 |
| Cessation of Continuous Flow Left Ventricular Assist Device-Related Gastrointestinal Bleeding After Heart Transplantation |
4 |